# US 2023/0414674 A1 · Methods and compositions for hair follicle generation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0414674 A1
- Document ID: US20230414674A1
- Status: Published application
- Kind: A1
- Application number: 18/325,745
- Filed: 2023-05-30
- Published: 2023-12-28
- Earliest claimed: 2022-05-31
- Assignees: Sanford Burnham Prebys Medical Discovery Institute
- Applicants: Sanford Burnham Prebys Medical Discovery Institute
- Inventors: Evan Y. SNYDER; Michel R. IBRAHIM
- Web page: https://patentgrep.com/patent/US20230414674A1

## CPC

- A61K 35/36: Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39)
- A61K 9/0021: {Intradermal administration, e.g. through microneedle arrays or needleless injectors}
- A61P 17/14: for baldness or alopecia
- C12N 5/0628: {Hair stem cells; Hair progenitors (mesenchymal stem cells from hair follicles C12N5/0666)}
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/155: Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
- C12N 2501/385: of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
- C12N 2506/02: from embryonic cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2513/00: 3D culture
- C12N 2533/54: Collagen; Gelatin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Described herein are compositions and methods useful for hair follicle generation comprising transplanting human pluripotent stem cell-derived hair follicle bulge stem cells, wherein the developmental and molecular requirements for the generation of hair follicle following transplantation is ensured.

## Claims

### Claim 1

A method of growing a hair follicle comprising:
(a) preparing human induced pluripotent stem cells (hiPSCs);
(b) differentiating the hiPSCs into hair follicle bulge stem cells (HFBSCs); and
(c) implanting the HFBSCs into skin of a subject, wherein the subject is a human subject.

### Claim 2 (depends on 1)

The method of claim 1, wherein the hiPSCs have one, two, three, four, five, six, or more markers selected from the group consisting of CD200, ITGA6, ITGB1, OCT4, NANOG, SOX2, TRA-1-60, TRA-1-81, and SSEA4.

### Claim 3 (depends on 1)

The method of claim 1, wherein the HFBSCs have one, two, three, four, five, six, or seven markers selected from the group consisting of CD200, ITGA6, ITGB1, KRT15, KRT18, KRT19, and P63.

### Claim 4 (depends on 1)

The method of claim 1, wherein the preparing in (a) comprises introducing, by electroporation, non-integrating episomal plasmid vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28 and an shRNA for human p531.

### Claim 5 (depends on 4)

The method of claim 4, wherein the electroporation is via a Neon transfection system.

### Claim 6 (depends on 1)

The method of claim 1, wherein the differentiating in (b) comprises formation of embryoid bodies (EBs) in a floating culture.

### Claim 7 (depends on 6)

The method of claim 6, wherein the differentiating in (b) comprises plating the EBs onto coated plates.

### Claim 8 (depends on 7)

The method of claim 7, wherein the coated plates are collagen I coated plates.

### Claim 9 (depends on 1)

The method of claim 1, further comprising, prior to (c), (b1) differentiating the hiPSCs into keratinocytes.

### Claim 10 (depends on 9)

The method of claim 9, wherein the differentiating in (b1) comprises employing all-trans retinoic acid (ATRA) and L-ascorbic acid (L-AA) to induce the hiPSC to form ectoderm and then the addition of bone morphogenic protein-4 (BMP-4) and epidermal growth factor (EGF).

### Claim 11 (depends on 10)

The method of claim 10, wherein the differentiating in (b1) is according to a sequential differentiation protocol.

### Claim 12 (depends on 1)

The method of claim 1, wherein the implanting in (c) comprises intradermal injection, or the implanting in (c) occurs at 15-19 days in vitro (DIV).

### Claim 13

(canceled)

### Claim 14 (depends on 12)

The method of claim 12, wherein the implanting in (c) occurs 16-18 DIV.

### Claim 15 (depends on 1)

The method of claim 1, wherein the HFBSCs have not yet started expressing the keratinocyte associated molecules KRT5 and KRT14.

### Claim 16 (depends on 1)

The method of claim 1, further comprising treating hair loss and/or a condition in the subject in need thereof, the condition is alopecia, ectodermal dysplasia, monilethrix, Netherton syndrome, Menkes disease, or hereditary epidermolysis bullosa.

### Claim 17

(canceled)

### Claim 18

A composition, comprising (a) hair follicle bulge stem cells (HFBSCs); and (b) media, wherein the HFBSCs express markers CD200, ITGA6, ITGB1, KRT15, KRT18, KRT19, and P63.

### Claim 19 (depends on 18)

The composition of claim 18, wherein the HFBSCs do not express the keratinocyte associated molecules KRT5 or KRT14.

### Claim 20 (depends on 19)

The composition of claim 19, wherein the composition is made by a process comprising:
(a) preparing human induced pluripotent stem cells (hiPSCs); and
(b) differentiating the hiPSCs into the HFBSCs.

### Claim 21 (depends on 20)

The composition of claim 20, wherein the hiPSCs have one, two, three, four, five, six, or more markers selected from the group consisting of CD200, ITGA6, ITGB1, OCT4, NANOG, SOX2, TRA-1-60, TRA-1-81 and SSEA4.

### Claim at position 22

22-26. (canceled)

### Claim 27

A method for hair follicle replacement, the method comprising:
a. obtaining human pluripotent stem cells (hPSCs), wherein the hPSCs are human induced pluripotent stem cells derived hair follicle bulge stem cells (hiPSC-HFBSC);
b. differentiating the hPSCs, thereby producing differentiated hPSCs toward becoming keratinocytes;
c. capturing and isolating at least a portion of the differentiated hPSCs, wherein the portion of the differentiated hPSCs expresses hair follicle bulge stem cell markers (HFBSCM); and
d. transplanting the portion of the differentiated hPSCs into a patient in need thereof, wherein the patient is a human.

### Claim at position 24

28-46. (canceled)
